Patents by Inventor Thomas Alfred Inglin
Thomas Alfred Inglin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10786479Abstract: The invention provides a method of inhibiting the conversion of carnitine to trimethylamine (TMA) and lowering TMAO in an individual comprising administering to the individual one or more compositions comprising a compound set forth in Formula (I): Wherein the compound is administered in an amount effective to inhibit conversion of carnitine to TMA in the individual.Type: GrantFiled: December 1, 2016Date of Patent: September 29, 2020Assignees: The Procter & Gamble Company, The Cleveland Clinic FoundationInventors: Stanley Leon Hazen, Jose Carlos Garcia-Garcia, George Franklin Gerberick, John August Wos, David Thomas Stanton, Thomas Alfred Inglin, Michael Reilly, Angela Jane Deutsch, Jodie Michele Reed, David Blair Cody
-
Patent number: 10780072Abstract: The invention provides one or more methods of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual comprising administering to the individual one or more compositions comprising a compound set forth in Formula (I): wherein the compound is administered in an amount effective to inhibit formation of trimethylamine (TMA) from choline in the individual.Type: GrantFiled: December 1, 2016Date of Patent: September 22, 2020Assignees: The Procter & Gamble Company, The Cleveland Clinic FoundationInventors: Stanley Leon Hazen, Jose Carlos Garcia-Garcia, George Franklin Gerberick, John August Wos, David Thomas Stanton, Thomas Alfred Inglin, Michael Reilly, Angela Jane Deutsch, Jodie Michele Reed, David Blair Cody
-
Publication number: 20170151208Abstract: The invention provides one or more methods of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual comprising administering to the individual one or more compositions comprising a compound set forth in Formula (I): wherein the compound is administered in an amount effective to inhibit formation of trimethylamine (TMA) from choline in the individual.Type: ApplicationFiled: December 1, 2016Publication date: June 1, 2017Inventors: Stanley Leon HAZEN, Jose Carlos GARCIA-GARCIA, George Franklin GERBERICK, John August WOS, David Thomas STANTON, Thomas Alfred INGLIN, Michael REILLY, Angela Jane DEUTSCH, Jodie Michele REED, David Blair CODY
-
Publication number: 20170151250Abstract: The invention provides a method of inhibiting the conversion of carnitine to trimethylamine (TMA) and lowering TMAO in an individual comprising administering to the individual one or more compositions comprising a compound set forth in Formula (I): Wherein the compound is administered in an amount effective to inhibit conversion of carnitine to TMA in the individual.Type: ApplicationFiled: December 1, 2016Publication date: June 1, 2017Inventors: Stanley Leon HAZEN, Jose Carlos GARCIA-GARCIA, George Franklin GERBERICK, John August WOS, David Thomas STANTON, Thomas Alfred INGLIN, Michael REILLY, Angela Jane DEUTSCH, Jodie Michele REED, David Blair CODY
-
Publication number: 20170087056Abstract: A blister card with a back side and a front side opposite the back side. The front side has a plurality of blisters and each blister contains a unit dose and each unit dose contains an active. Each blister card contains from about 12 hours to about 24 hours of unit doses according to the dosage instructions. The actives can be the same or different.Type: ApplicationFiled: November 17, 2016Publication date: March 30, 2017Inventors: Rosa Manuela Leon Alonso, Kelly Lee Schmeichel, Isabelle La Fosse-Marin, Angela Jane Deutsch, Thomas Alfred Inglin, Kurt Franklin Trombley, Diane Danheiser Powers, Eduardo De Abreu Mangione, Craig Andrew Hawkins, Jay Robert Morosey, JR.
-
Patent number: 9526673Abstract: A portable blister card including a front side and a back side opposite the front side. The front side includes a face having a width, a right side edge, a left side edge, a top edge, and an outer periphery. In addition, the front side includes a first blister and a second blister extending outwardly at the face and a primary manufacturer indicia area comprising a manufacturer indicator visible on the front side. The first blister contains a first unit dose and the second blister contains a second unit dose, wherein the first and second unit doses are different. The back side includes regulatory information that remains on the back side when each unit dose is removed from each blister through the back side of the card.Type: GrantFiled: March 11, 2016Date of Patent: December 27, 2016Assignee: The Procter & Gamble CompanyInventors: Rosa Manuela Leon Alonso, Kelly Lee Schmeichel, Isabelle La Fosse-Marin, Angela Jane Deutsch, Thomas Alfred Inglin, Kurt Franklin Trombley, Diane Danheiser Powers, Eduardo De Abreu Mangione, Craig Andrew Hawkins, Jay Robert Morosey, Jr.
-
Patent number: 9445970Abstract: A daily blister card housing a unit dose includes a back side and a front side opposite the back side. The front side includes a manufacturer indicator visible on the front side. A face has an outer periphery and a total planar area bounded by the outer periphery. One or more blisters extend outwardly at the face that contains at least three unit doses that are visible from outside the one or more blisters. Each of the one or more blisters includes a shoulder contacting a cavity backing surface and a projected cavity area bounded by the shoulder that is projected onto the cavity backing surface. A total projected cavity area of the one or more blisters is no more than about 45 percent of the total planar area bounded by the outer periphery.Type: GrantFiled: March 28, 2014Date of Patent: September 20, 2016Assignee: The Procter & Gamble CompanyInventors: Rosa Manuela Leon Alonso, Kelly Lee Schmeichel, Isabella La Fosse-Marin, Angela Jane Deutsch, Thomas Alfred Inglin, Kurt Franklin Trombley, Diane Danheiser Powers, Eduardo De Abreu Mangione, Craig Andrew Hawkins, Jay Robert Morosey, Jr.
-
Publication number: 20160193112Abstract: A blister card with a back side and a front side opposite the back side. The front side has a plurality of blisters and each blister contains a unit dose and each unit dose contains an active. Each blister card contains from about 12 hours to about 24 hours of unit doses according to the dosage instructions. The actives can be the same or different.Type: ApplicationFiled: March 11, 2016Publication date: July 7, 2016Inventors: Rosa Manuela Leon Alonso, Kelly Lee Schmeichel, Isabelle La Fosse-Marin, Angela Jane Deutsch, Thomas Alfred Inglin, Kurt Franklin Trombley, Diane Danheiser Powers, Eduardo De Abreu Mangione, Craig Andrew Hawkins, Jay Robert Morosey, JR.
-
Patent number: 9314402Abstract: A conveniently portable daily blister card including a front side and a back side opposite the front side. The front side includes a face having a width, a right side edge, a left side edge, a top edge, and an outer periphery. In addition, the front side includes at least three blisters extending outwardly at the face and a primary manufacturer indicia area. Each blister contains a unit dose. The back side includes regulatory information that remains on the back side when a unit dose is removed from a blister through the back side of the card.Type: GrantFiled: November 5, 2014Date of Patent: April 19, 2016Assignee: The Procter & Gamble CompanyInventors: Rosa Manuela Leon Alonso, Kelly Lee Schmeichel, Isabelle La Fosse-Marin, Angela Jane Deutsch, Thomas Alfred Inglin, Kurt Franklin Trombley, Diane Danheiser Powers, Eduardo De Abreu Mangione, Craig Andrew Hawkins, Jay Robert Morosey, Jr.
-
Publication number: 20150272826Abstract: A daily blister card housing a unit dose includes a back side and a front side opposite the back side. The front side includes a manufacturer indicator visible on the front side. A face has an outer periphery and a total planar area bounded by the outer periphery. One or more blisters extend outwardly at the face that contains at least three unit doses that are visible from outside the one or more blisters. Each of the one or more blisters includes a shoulder contacting a cavity backing surface and a projected cavity area bounded by the shoulder that is projected onto the cavity backing surface. A total projected cavity area of the one or more blisters is no more than about 45 percent of the total planar area bounded by the outer periphery.Type: ApplicationFiled: March 28, 2014Publication date: October 1, 2015Applicant: The Procter & Gamble CompanyInventors: Rosa Manuela Leon Alonso, Kelly Lee Schmeichel, Isabella La Fosse-Marin, Angela Jane Deutsch, Thomas Alfred Inglin, Kurt Franklin Trombley, Diane Danheiser Powers, Eduardo de Abreu Mangione, Craig Andrew Hawkins, Jay Robert Morosey, JR.
-
Publication number: 20150068930Abstract: A blister card with a back side and a front side opposite the back side. The front side has a plurality of blisters and each blister contains a unit dose and each unit dose contains an active. Each blister card contains from about 12 hours to about 24 hours of unit doses according to the dosage instructions. The actives can be the same or different.Type: ApplicationFiled: November 5, 2014Publication date: March 12, 2015Inventors: Rosa Manuela Leon Alonso, Kelly Lee Schmeichel, Isabelle La Fosse-Marin, Angela Jane Deutsch, Thomas Alfred Inglin, Kurt Franklin Trombley, Diane Danheiser Powers, Eduardo De Abreu Mangione, Craig Andrew Hawkins, Jay Robert Morosey, JR.
-
Patent number: 8905237Abstract: A blister card with a back side and a front side opposite the back side. The front side has a plurality of blisters and each blister contains a unit dose and each unit dose contains an active. Each blister card contains from about 12 hours to about 24 hours of unit doses according to the dosage instructions. The actives can be the same or different.Type: GrantFiled: December 16, 2011Date of Patent: December 9, 2014Assignee: The Procter & Gamble CompanyInventors: Rosa Manuela Leon Alonso, Kelly Lee Schmeichel, Isabelle LaFosse-Marin, Angela Jane Deutsch, Thomas Alfred Inglin, Kurt Franklin Trombley, Diane Danheiser Powers, Eduardo de Abreu Mangione, Craig Andrew Hawkins, Jay Robert Morosey, Jr.
-
Patent number: 8752704Abstract: A daily blister card housing a unit dose includes a back side and a front side opposite the back side. The front side includes a manufacturer indicator visible on the front side. A face has an outer periphery and a total planar area bounded by the outer periphery. One or more blisters extend outwardly at the face that contain at least three unit doses that are visible from outside the one or more blisters. Each of the one or more blisters includes a shoulder contacting a cavity backing surface and a projected cavity area bounded by the shoulder that is projected onto the cavity backing surface. A total projected cavity area of the one or more blisters is no more than about 45 percent of the total planar area bounded by the outer periphery.Type: GrantFiled: December 17, 2010Date of Patent: June 17, 2014Assignee: The Procter & Gamble CompanyInventors: Rosa Manuela Leon Alonso, Kelly Lee Schmeichel, Isabelle LaFosse-Marin, Angela Jane Deutsch, Thomas Alfred Inglin, Kurt Franklin Trombley, Diane Danheiser Powers, Eduardo de Abreu Mangione, Craig Andrew Hawkins, Jay Robert Morosey, Jr.
-
Publication number: 20120152795Abstract: A daily blister card housing a unit dose includes a back side and a front side opposite the back side. The front side includes a manufacturer indicator visible on the front side. A face has an outer periphery and a total planar area bounded by the outer periphery. One or more blisters extend outwardly at the face that contain at least three unit doses that are visible from outside the one or more blisters. Each of the one or more blisters includes a shoulder contacting a cavity backing surface and a projected cavity area bounded by the shoulder that is projected onto the cavity backing surface. A total projected cavity area of the one or more blisters is no more than about 45 percent of the total planar area bounded by the outer periphery.Type: ApplicationFiled: December 17, 2010Publication date: June 21, 2012Applicant: THE PROCTER & GAMBLE COMPANYInventors: Rosa Manuela Leon Alonso, Kelly Lee Schmeichel, Isabelle LaFosse-Marin, Angela Jane Deutsch, Thomas Alfred Inglin, Kurt Franklin Trombley, Diane Danheiser Powers, Eduardo de Abreu Mangione, Craig Andrew Hawkins
-
Publication number: 20120152796Abstract: A blister card with a back side and a front side opposite the back side. The front side has a plurality of blisters and each blister contains a unit dose and each unit dose contains an active. Each blister card contains from about 12 hours to about 24 hours of unit doses according to the dosage instructions. The actives can be the same or different.Type: ApplicationFiled: December 16, 2011Publication date: June 21, 2012Inventors: Rosa Manuela Leon Alonso, Kelly Lee Schmeichel, Isabelle LaFosse-Marin, Angela Jane Deutsch, Thomas Alfred Inglin, Kurt Franklin Trombley, Diane Danheiser Powers, Eduardo de Abreu Mangione, Craig Andrew Hawkins
-
Publication number: 20080275113Abstract: The present invention comprises an antimicrobial composition. More particularly to an antimicrobial composition that comprises a. from about 0.01% to about 15% of at least one non-anionic surfactant, by weight of the composition; b. from about 0.01% to about 15% of at least one acid, by weight of the composition; c. from about 0% to about 99.85% of water, by weight of the composition; and wherein the composition is foaming.Type: ApplicationFiled: May 2, 2008Publication date: November 6, 2008Inventors: Thomas Edward Huetter, Thomas Alfred Inglin, Timothy Woodrow Coffindaffer, Kelly Lee Martin, Brian Gilbert Leukart, Dennis Eugene Kuhlman
-
Patent number: 5733272Abstract: The present invention comprises compositions and articles such as catamenials, diapers, pantiliners, adult incontinence garments, and underarm shields which minimize odor caused by body fluids and which provide a pleasant scent signal to indicate that the odor is being removed. This scent signal, provided by cyclodextrin/perfume inclusion complexes and/or matrix perfume microcapsules, assures the wearer that the product is working.Type: GrantFiled: June 6, 1995Date of Patent: March 31, 1998Assignee: The Procter & Gamble CompanyInventors: Gordon Francis Brunner, Toan Trinh, Thomas Alfred Inglin